News

In May 2012 PBB and PolyTherics signed an agreement to undertake a feasibility programme to evaluate the use of TheraPEG technology to develop a long-acting (polyethylene glycol)PEGylated form

Xyrem (sodium oxybate) oral solution is the FDA approved product for the treatment of both cataplexy and excessive daytime sleepiness in patients with narcolepsy. The new patent entitled

The software allows biotech customers to leverage Bruker’s mass spectrometry for intact protein and post-translational modification analysis in a routine industrial biologics environment. The solution introduced techniques for

The renaming allows uniting several healthcare IT brands under the single name "M*Modal" to supply Speech Understanding and Natural Language Understanding technologies. M*Modal chairman and CEO Vern Davenport

The clinical study is part of University of Oxford’s DOLAB trial funded by a grant from DSM Nutritional Products. The study primarily focused on DSM’s algal DHA omega-3

CML president and CEO Brian Scanlan said CML supports both increasing demand for its commercial products as well as its healthy pipeline of API’s in later phases of

Gujarat Food and Drugs Control Administration (FDCA) commissioner H G Koshia was quoted by Business Standard as saying that Biocon has approached the state government for land to

The award will fund preclinical development of StemCells’ proprietary HuCNS-SC product candidate in Alzheimer’s disease over a four-year period, with the goal of filing an investigational new drug

The disposable set-up is expected to ease process transfers, smooth outsourcing concepts and help Lean-to-Clinic program from gene to drug product in 16 months. Boehringer Ingelheim’s disposable set-up